Concord Medical says 2024-25 accounts unreliable
CCM is changing auditors and plans to restate 2024–2025 financials after SEC staff comments and its own conclusion that prior statements should no longer be relied upon.
Rhea-AI Filing Summary
Concord Medical Services Holdings Ltd (CCM) reports the resignation of Shandong Haoxin Certified Public Accountants as its independent auditor on September 14, 2026 and the appointment of Guangdong Prouden CPAs GP on September 22, 2026, approved by the audit committee.
The company states that prior audit reports for 2024 and 2025 contained an explanatory paragraph about its ability to continue as a going concern and that it has a material weakness due to insufficient U.S. GAAP and SEC reporting expertise. Following SEC staff comments asserting that Concord Medical lost its controlling financial interest in Concord Healthcare Group Co., Ltd. in 2024, the company has concluded that its audited consolidated financial statements for 2024 and 2025 should no longer be relied upon and will be restated to deconsolidate CHG effective in 2024 via an amended Form 20-F for 2025.
Positive
- None.
Negative
- Previously issued 2024 and 2025 financial statements no longer reliable, with the company intending to restate them to reflect deconsolidation of Concord Healthcare Group Co., Ltd. effective in 2024.
- Audit reports for 2024 and 2025 included an explanatory paragraph on the company’s ability to continue as a going concern.
- The company discloses a material weakness in internal control related to a lack of accounting staff and resources with appropriate U.S. GAAP and SEC reporting knowledge.
- Resignation of the prior independent registered public accounting firm, Shandong Haoxin, on September 14, 2026 adds uncertainty around financial reporting.
- Financial reporting timing and outcome are uncertain due to the restatement process, completion of audit procedures, and potential additional accounting adjustments.
Key Figures
Auditor resignation date: September 14, 2026
New auditor engagement date: September 22, 2026
Fiscal years to be restated: 2024 and 2025
+2 more
5 metrics
Auditor resignation date
September 14, 2026
Date Shandong Haoxin resigned as independent registered public accounting firm
New auditor engagement date
September 22, 2026
Date Guangdong Prouden CPAs GP was engaged as new auditor
Fiscal years to be restated
2024 and 2025
Years for which audited consolidated financial statements will be restated
SEC staff comment letter date
August 27, 2026
Date of SEC Division of Corporation Finance staff letter on 2025 Form 20-F
Effective year of CHG deconsolidation
2024
Year from which Concord Healthcare Group Co., Ltd. will be deconsolidated
Key Terms
material weakness, going concern, deconsolidation, ASC 810-10-15-10, +2 more
6 terms
material weakness financial
"except for (i) the material weakness related to the lack of accounting staff"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
going concern financial
"except for an explanatory paragraph regarding the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
deconsolidation financial
"will need to be restated to reflect the deconsolidation of CHG effective in the year of 2024"
Deconsolidation occurs when a company stops combining another business’s financial results and balances with its own—usually because it no longer controls that business. For investors this matters because it can suddenly shrink reported revenue, assets, debt and profit, or create a one‑time gain or loss, changing how risky or profitable the remaining company appears; think of it like removing a roommate from a shared household budget and seeing your monthly totals change.
ASC 810-10-15-10 financial
"restat[e] its financial statements in accordance with ASC 810-10-15-10, ASC 810-10-25-1"
Regulation S-X regulatory
"and Article 3A-02 of Regulation S-X"
A set of U.S. securities rules that prescribes how public companies must prepare, present and have audited their financial statements and related exhibits. It lays out formats, required schedules and minimum disclosure standards so financial reports follow a consistent structure. For investors, this consistency and verification act like a standard recipe and inspection checklist, making financial statements easier to compare, trust and use for valuation decisions.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why is CCM restating its 2024 and 2025 financial statements?
The company concluded its audited 2024 and 2025 financial statements should no longer be relied upon after SEC staff commented that it lost its controlling financial interest in Concord Healthcare Group Co., Ltd. in 2024 and requested restatement to deconsolidate CHG.
What change in auditor did CCM disclose in this Form 6-K?
On September 14, 2026, Shandong Haoxin resigned as CCM’s independent registered public accounting firm. On September 22, 2026, the company engaged Guangdong Prouden CPAs GP as its new independent registered public accounting firm, with approval from the audit committee.
Did CCM’s prior auditor reports for 2024 and 2025 include a going concern issue?
Yes. Shandong Haoxin’s audit reports for 2024 and 2025 did not contain adverse opinions but included an explanatory paragraph regarding CCM’s ability to continue as a going concern, highlighting uncertainty about its ongoing viability.
What material weakness in internal control did CCM report?
CCM reports a material weakness related to a lack of accounting staff and resources with appropriate knowledge of U.S. GAAP and SEC reporting and compliance, identified as a reportable event in connection with its financial reporting.
How will CCM implement the financial restatement for symbol CCM?
CCM intends to file an amendment to its Form 20-F for 2025, which will include restated consolidated financial statements for the years ended December 31, 2024 and 2025, reflecting the deconsolidation of CHG effective in 2024.
Were there disagreements between CCM and its former auditor Shandong Haoxin?
CCM states there were no disagreements, as defined in Form 20-F, with Shandong Haoxin on accounting principles, financial statement disclosure, or auditing scope or procedure during 2024, 2025, and the subsequent interim period before resignation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
